Brief: Sio Gene Therapies To Sell Arvelle Stake As Part Of Angelini Pharma’S Acquisition Of Arvelle Therapeutics

Sio Gene Therapies

04/01/2021 13:45

Jan 4 (Reuters) - Sio Gene Therapies Inc  SIOX.O :
    * SIO GENE THERAPIES TO SELL ARVELLE STAKE AS PART OF
ANGELINI
PHARMA’S ACQUISITION OF ARVELLE THERAPEUTICS
    * SIO GENE THERAPIES INC - TO RECEIVE UP TO $20 MILLION IN
UPFRONT
AND MILESTONE PAYMENTS FROM NON-DILUTIVE TRANSACTION
    * SIO GENE THERAPIES INC - TRANSACTION EXTENDS CASH RUNWAY
INTO
2022
    * SIO GENE THERAPIES INC - EXPECTS TO RECEIVE AN UPFRONT
PAYMENT
OF $11.8 MILLION, AND $8.2 MILLION IN REGULATORY AND SALES
MILESTONE PAYMENTS
    * SIO GENE THERAPIES - TO SELL STAKE IN ARVELLE THERAPEUTICS
TO
ANGELINI PHARMA, AS PART OF CASH ACQUISITION OF 100% OF STOCK OF
ARVELLE THERAPEUTICS FOR UP TO $960 MILLION

Source text for Eikon:  ID:nGNX2JBKNp 
Further company coverage:  SIOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))